Skip to main content

Dicerna Pharmaceuticals and Alnylam Pharmaceuticals settle suits

Dicerna Pharmaceuticals Inc. (Nasdaq: DRNA) and Alynylam Pharmaceuticals Inc. (Nasdaq: ALNY) settled a stolen trade secrets case. Shares of Dicerna Pharmaceuticals soared $1.82 to close at $12.01 while Alnylam Pharmaceuticals' stock gained $1.29 to close at $97.48.


Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.